4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-000921
Chief Financial Officer sold 10,945 shares at an average $5.86 ($64,187)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NOUGUES MAXIMO F Chief Financial Officer | 2026-01-06 | Sale 10b5-1 | −4,540 | $5.84 | $26,532 | 199,689 | D |
| NOUGUES MAXIMO F Chief Financial Officer | 2026-01-07 | Sale 10b5-1 | −6,405 | $5.88 | $37,655 | 193,284 | D |
| Open-market sales · 10,945 sh · avg $5.86 · $64,187 | |||||||
Loading xslF345X05/rdgdoc.xml…